Finally! Prevention of Diabetes is HERE!

For 4 years, symptoms 602 pre-diabetic patients were studied to see whether or not a drug called Pioglitazone (an insulin sensitizer) cured Type-2 diabetes. Participants were at high risk of developing diabetes, obese and were prone through hereditary of developing diabetes in the future.

The Result

The study which was conducted at the Pennington Biomedical Research Center, concluded that the drug pioglitazone, marketed as “Actos” for the treatment of diabetes (pictured above), actually reduced the risk of developing diabetes by 72%!

There’s More

Pioglitazone performed a lot better than originally anticipated by improving blood pressure and HDL cholesterol levels. In addition, it slowed the risk of developing cardiovascular diseases.

For Entertainment Purposes Only

CONSULT YOUR DOCTOR FIRST. This post is meant to keep you up to date on the world of health and fitness.

Be The First To Comment.

Leave A Reply





Copyright © Designed by